Ducommun INC (NYSE: DCO) Director Richard A. Baldridge executed multiple sales of company stock on March 10, 2026, disposing of 10,440 shares for roughly $1.36 million. The trades were carried out at prices spanning $130.00 to $132.41 per share.
After the sale, Baldridge retains direct ownership of 20,100 shares of Ducommun common stock. The transaction coincides with a period of strong share-price performance for the company, which has risen 119% over the last year and was trading at $125.68 at the time of the reporting, giving the company a market capitalization of about $1.88 billion.
Valuation and analyst context
InvestingPro's analysis flags the stock as appearing overvalued relative to its Fair Value estimate and lists it among candidates for a Most Overvalued stocks compilation. At the same time, sell-side analysts retained a constructive stance on the equity, publishing price targets in a range from $134 to $155.
Quarterly results and market reaction
Ducommun's fourth-quarter 2025 financial report included an adjusted earnings per share (EPS) of $1.05, which exceeded the $0.96 analyst expectation. Revenue for the quarter came in at $215.8 million, narrowly below the forecasted $217.35 million. Despite the EPS beat, the company’s shares reacted negatively to the report and closed at $126.77, a level noted as below the stock's 52-week high.
Broader context and resources
The insider sale and quarterly results together contribute to the recent developments surrounding Ducommun's equity. For readers seeking expanded valuation context and performance analysis, InvestingPro lists 12 additional ProTips along with Pro Research Reports that cover over 1,400 U.S. equities.
The transaction by Baldridge and the company’s reported quarter present a mixed picture: an insider reducing holdings amid a strong 12-month rally, a valuation assessment that leans toward overvaluation, and financial results that beat on EPS but slightly missed on revenue.